What is Ampronix?
Ampronix has established itself as a leading authorized master distributor for top medical industry brands and a world-class manufacturer of innovative medical technology. Since its inception in 1982, the company has been committed to addressing the evolving needs of the medical community through extensive product expertise, exceptional service, and a state-of-the-art repair facility. Ampronix specializes in delivering customized, comprehensive solutions that are both faster and more cost-effective than those offered by other manufacturers. Its operations are certified under ISO 13485:2003, ISO 9001:2008, and ANSI/ESD S20.20-2007, highlighting a strong commitment to quality and industry standards.
How much funding has Ampronix raised?
Ampronix has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Ampronix
PPP
Public-Private Partnership
What's next for Ampronix?
The substantial late-stage funding and strategic investment signal a pivotal moment for Ampronix, positioning the company for accelerated growth and market penetration. This influx of capital is expected to fuel advancements in its manufacturing capabilities, expand its distribution network, and potentially support research and development for new technological innovations. Ampronix's focus on providing tailored, efficient solutions, combined with its strong industry certifications, suggests a strategic direction aimed at solidifying its leadership in the medical device market and further enhancing its service offerings to healthcare providers globally.
See full Ampronix company page
